Scientists have found a connection between bacteria in the gut and antitumor immune responses in the liver. Their study, published
Continue reading »Home ยป
Expansion of circulating tumor-specific T cells after treatment suggested systemic antitumor immunity
The anti-PD1 immunotherapy nivolumab (Opdivo) given prior to surgical resection of stage 1-3 non-small cell lung cancer (NSCLC) was safe
Continue reading »